Skip to content

Company information lookup


Developer of products to treat various cancers and chronic inflammatory diseases

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
CDY 0.025 4.17% 0.024 0.025 0.024 0.025 0.024 1,069,122


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code CDY
Official Listing Date 9 December, 2005
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address
Registered Office Address Level 6, Suite 1802, Level 18, 15 Castlereagh Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone (02) 9299 0311
Head Office Fax (02) 9299 2198
Share Registry Telephone (02) 9290 9600
Directors / Senior Management
Dr David King (Chairman, Non Exec. Director)
Ms Maria Julianna Halasz, BSc, MBA (Managing Director, CEO)
Mr Graeme Kaufman (Non Exec. Director)
Mr Martin Rogers (Non Exec. Director)
Ms Jillian McGregor (General Counsel)
Company Secretary Ms Jillian McGregor
Mr Nicholas Falzon
Principal Activities Developer of products to treat various cancers and chronic inflammatory diseases

CELLMID LIMITED announcements

How are company announcements published on

Date Price
Headline Pages PDF
15/04/2014   Cellmid Signs Mk Tribody Collaboration Agreement 3 PDF
31/03/2014   Presentation to the Market 28 PDF
24/03/2014   Cellmid News 8 PDF
27/02/2014 asterix Appendix 4D and Half Yearly Accounts 20 PDF
17/02/2014   Cleansing Notice and Appendix 3B 10 PDF
10/02/2014 asterix USA RNA/DNA Patent for Surgical Adhesion Allowed 2 PDF
29/01/2014 asterix Chinese Distribution Agreement Signed for Hair Loss Products 2 PDF
28/01/2014 asterix Appendix 4C - quarterly 6 PDF
08/01/2014   Response to ASX Query 3 PDF
06/01/2014   Change of Director's Interest Notice - Maria Halasz 3 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 Apr 2014 0.025 4.17% 0.025 0.024 1,069,122
16 Apr 2014 0.024 0% 0.024 0.023 1,387,769
15 Apr 2014 0.024 0% 0.025 0.024 5,842,121
14 Apr 2014 0.024 -11.11% 0.026 0.024 3,495,239
11 Apr 2014 0.027 3.85% 0.027 0.025 5,808,107

* Volume of shares shown represents only those shares traded on ASX.

CELLMID LIMITED price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security CDY. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security CDY

Warrants & Structured Products

No warrants & Structured Products are available over the security CDY


No Contracts For Differences are available over the security CDY